The IsoSpark Duo platform’s predictive immune response enables quality assessments of cell immunotherapies and improved assessment of clinical response and mechanism of action in patient samples.

The automated IsoSpark Duo platform, which runs the IsoCode and CodePlex Chips, is a versatile, precision automation platform designed to understand and characterize differences among immune cells, mapping thousands of cells per sample to reveal complete functional profiles and polyfunctionality among cell subsets.